Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antihypertensive treatment in coronary heart disease with isolated central hypertension
ChiCTR2000035758Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alisartan, amlodipine and Placebo-COD Research Private Ltd in coronary arteriosclerosis and Central hypertension (CH) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Major adverse cardiovascular events. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
alisartanamlodipinePlacebo-COD Research Private Ltd
03
Conditions
coronary arteriosclerosisCentral hypertension (CH)
Beyond the preview
Go deeper on ChiCTR2000035758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035758.